We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+74.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.46B
AUM Growth
+$1.09B
Cap. Flow
-$3.1M
Cap. Flow %
-0.07%
Top 10 Hldgs %
49.45%
Holding
523
New
34
Increased
205
Reduced
238
Closed
35

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$149M
2
AMD icon
Advanced Micro Devices
AMD
+$114M
3
ASML icon
ASML
ASML
+$83.3M
4
INTC icon
Intel
INTC
+$69.9M
5
KLAC icon
KLA
KLAC
+$61.9M

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$172M
2
AXTI icon
AXT Inc
AXTI
+$110M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.9M
4
GLW icon
Corning
GLW
+$87.2M
5
TSEM icon
Tower Semiconductor
TSEM
+$79.8M

Sector Composition

Rank Sector Weight
1 Technology 66.9%
2 Consumer Discretionary 12.6%
3 Communication Services 5.91%
4 Miscellaneous 3.42%
5 Healthcare 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
251
Rhythm Pharmaceuticals
RYTM
$7.04B
$528K 0.01%
4,751
-1,702
-26% -$154K
UBER icon
252
Uber
UBER
$154B
$527K 0.01%
7,303
-369
-5% -$27.1K
CAH icon
253
Cardinal Health
CAH
$57.3B
$526K 0.01%
2,214
-132
-6% -$27.4K
CGON icon
254
CG Oncology
CGON
$6.55B
$526K 0.01%
7,400
-1,379
-16% -$90.1K
HCA icon
255
HCA Healthcare
HCA
$87.3B
$524K 0.01%
1,343
+180
+15% +$76.1K
KVUE icon
256
Kenvue
KVUE
$36.3B
$522K 0.01%
+27,323
New +$481K
CYTK icon
257
Cytokinetics
CYTK
$10.1B
$522K 0.01%
6,123
-3,027
-33% -$217K
PCVX icon
258
Vaxcyte
PCVX
$9.09B
$517K 0.01%
8,898
-1,201
-12% -$65.2K
MIRM icon
259
Mirum Pharmaceuticals
MIRM
$6.19B
$513K 0.01%
4,386
-1,961
-31% -$197K
SRRK icon
260
Scholar Rock
SRRK
$6.74B
$509K 0.01%
9,256
-4,193
-31% -$203K
NCLH icon
261
Norwegian Cruise Line
NCLH
$7.19B
$507K 0.01%
24,040
+424
+2% +$7.91K
CTSH icon
262
Cognizant
CTSH
$28.1B
$507K 0.01%
13,079
-15,174
-54% -$799K
HUM icon
263
Humana
HUM
$48.3B
$504K 0.01%
1,268
-967
-43% -$275K
COGT icon
264
Cogent Biosciences
COGT
$6.05B
$500K 0.01%
12,928
-3,176
-20% -$111K
SLS icon
265
SELLAS Life Sciences
SLS
$2.82B
$499K 0.01%
33,825
+2,471
+8% +$17.1K
BSX icon
266
Boston Scientific
BSX
$69.1B
$498K 0.01%
11,657
+1,802
+18% +$97.8K
CDE icon
267
Coeur Mining
CDE
$22.1B
$497K 0.01%
30,464
-9,178
-23% -$167K
COR icon
268
Cencora
COR
$63.7B
$497K 0.01%
1,756
+140
+9% +$40.4K
TGTX icon
269
TG Therapeutics
TGTX
$8.57B
$497K 0.01%
9,040
-11,666
-56% -$477K
DNTH icon
270
Dianthus Therapeutics
DNTH
$6.02B
$497K 0.01%
5,094
+1,169
+30% +$102K
KRYS icon
271
Krystal Biotech
KRYS
$10.7B
$492K 0.01%
1,323
-958
-42% -$286K
BLK icon
272
Blackrock
BLK
$173B
$491K 0.01%
511
-17
-3% -$17.6K
EW icon
273
Edwards Lifesciences
EW
$51.7B
$489K 0.01%
5,407
-345
-6% -$28.9K
NTRA icon
274
Natera
NTRA
$47.1B
$488K 0.01%
1,798
-1,086
-38% -$232K
CDW icon
275
CDW
CDW
$19.1B
$485K 0.01%
3,451
-72
-2% -$9.04K
9 10
11
12 13

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, E Fund Management held 523 positions worth $4.46B, up 32% from $3.37B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

E Fund Management's Q2 2026 filing shows 34 new, 205 increased, 238 reduced and 35 closed positions. Its largest new stake was Astera Labs: 196,877 shares worth $95.1M. The largest sale was Lumentum, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 67% of assets, up from 52% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • E Fund Management's largest Q2 2026 buy was Astera Labs: 196,877 shares worth $95.1M.
  • E Fund Management added most to Lam Research in Q2 2026, an estimated $149M increase.
  • E Fund Management's biggest Q2 2026 reduction was Lumentum, cutting an estimated $172M.
  • E Fund Management fully exited SPDR Gold MiniShares Trust in Q2 2026, selling an estimated $13.4M.
  • E Fund Management's ten largest holdings make up 49% of its $4.46B portfolio in Q2 2026.
  • E Fund Management opened 34 new positions and closed 35 in Q2 2026.
  • E Fund Management's portfolio value rose 32% quarter-over-quarter to $4.46B.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.